BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
1984 results:

  • 1. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Radiolabelled FGF-2 for Imaging Activated Fibroblasts in the Tumor Micro-Environment.
    Bentivoglio V; Galli F; Varani M; Ranieri D; Nayak P; D'Elia A; Soluri A; Massari R; Lauri C; Signore A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672507
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Management of Nontraumatic Spontaneous Renal Hemorrhage (Wünderlich Syndrome) through Robotic-Assisted Laparoscopic Nephrectomy: A Case Series.
    Tao B; Zhang H; Zhang G; Liu H; Meng L; Zhu X; Ji X; Jia G; Qi A; Wang C
    Am J Case Rep; 2024 Apr; 25():e942826. PubMed ID: 38659203
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on renal cancer care.
    Yildirim H; Bins AD; van den Hurk C; van Moorselaar RJA; van Oijen MGH; Bex A; Zondervan PJ; Aben KKH
    World J Urol; 2024 Apr; 42(1):231. PubMed ID: 38613582
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy for overweight colon cancer patients: a case-control study.
    Zhou D; Su J; Yang X; Huang L; Zheng Z; Wei H; Fang J
    Langenbecks Arch Surg; 2024 Apr; 409(1):112. PubMed ID: 38587671
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characteristics of high frame frequency contrast-enhanced ultrasound in renal tumors.
    Zhang W; Wang J; Chen L
    BMC Med Imaging; 2024 Mar; 24(1):71. PubMed ID: 38528467
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
    Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
    J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
    Eigler C; McDougall L; Bauman A; Bernhardt P; Hentschel M; Blackham KA; Nicolas G; Fani M; Wild D; Cordier D
    J Nucl Med; 2024 Apr; 65(4):573-579. PubMed ID: 38423782
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
    Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
    Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Percutaneous Microwave Ablation for Treatment of Retroperitoneal tumors.
    Rossebo AE; Zlevor AM; Knott EA; Mao L; Couillard AB; Ziemlewicz TJ; Hinshaw JL; Abel EJ; Lubner MG; Knavel Koepsel EM; Wells SA; Stratchko LM; Laeseke PF; Lee FT
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230080. PubMed ID: 38334471
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Relative predictive value of sociodemographic factors for chronic diseases among All of Us participants: a descriptive analysis.
    Kunnath AJ; Sack DE; Wilkins CH
    BMC Public Health; 2024 Feb; 24(1):405. PubMed ID: 38326799
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [
    Zhang M; Kang F; Xing T; Wang J; Ma T; Li G; Quan Z; Yang W; Chen X; Wang J
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1713-1724. PubMed ID: 38216779
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Microwave-assisted UV digestion of starch and skimmed milk powder: Environmentally friendly protocol for essential and toxic elements determination.
    Ramos do Nascimento V; Pereira de Almeida D; Giacobe K; Marlon de Moraes Flores E; Augusto Bizzi C
    Talanta; 2024 Apr; 270():125575. PubMed ID: 38159353
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
    Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
    Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
    [No Abstract]    [Full Text] [Related]  

  • 15. Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types.
    Song WM; Elmas A; Farias R; Xu P; Zhou X; Hopkins B; Huang KL; Zhang B
    J Hematol Oncol; 2023 Dec; 16(1):120. PubMed ID: 38102665
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Off-clamp vs on-clamp robot-assisted partial nephrectomy: a systematic review and meta-analysis.
    Fong KY; Gan VHL; Lim BJH; Chan YH; Castellani D; Chen K; Tay KJ; Ho HSS; Yuen JSP; Aslim E; Teoh J; Lim EJ
    BJU Int; 2024 Apr; 133(4):375-386. PubMed ID: 38069544
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.
    Denize T; Jegede OA; Matar S; El Ahmar N; West DJ; Walton E; Bagheri AS; Savla V; Nabil Laimon Y; Gupta S; Vemula SV; Braun DA; Burke KP; Catalano PJ; Freeman GJ; Motzer RJ; Atkins MB; McDermott DF; Sharpe AH; Choueiri TK; Signoretti S
    Clin Cancer Res; 2024 Feb; 30(4):803-813. PubMed ID: 38060202
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
    Hahn AW; Surasi DS; Viscuse PV; Bathala TK; Wiele AJ; Campbell MT; Zurita AJ; Shah AY; Jonasch E; Gao J; Goswami S; Alhalabi O; Rao P; Sircar K; Tannir NM; Msaouel P
    Oncologist; 2024 May; 29(5):392-399. PubMed ID: 38035767
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Celastrol enhances TRAIL‑R2‑mediated apoptosis and cytotoxicity in human renal cell carcinoma cells in caspase‑dependent manner.
    Bao Y; Wu X; Kanematsu A; Kita Y; Kobayashi T; Kakehi Y; Yamamoto S
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37997857
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [
    Günther T; Holzleitner N; Viering O; Beck R; Wienand G; Dierks A; Pfob CH; Bundschuh RA; Kircher M; Lapa C; Wester HJ
    J Nucl Med; 2024 Jan; 65(1):33-39. PubMed ID: 37945383
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 100.